JAC Advance Access originally published online on January 16, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2004) 53, 144-148
© 2004 The British Society for Antimicrobial Chemotherapy
Review |
Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae
1 GR Micro Ltd., 79 William Road, London NW1 3ER, UK; 2 Public Health Research Institute, Newark, NJ, USA
This review focuses on the activity of gemifloxacin, a new respiratory fluoroquinolone, against the two most important bacterial pathogens associated with lower respiratory tract infections, namely Streptococcus pneumoniae and Haemophilus influenzae.
Keywords: fluoroquinolones, respiratory tract infections, fluoroquinolone resistance, community-acquired pneumonia, acute exacerbation of chronic bronchitis
* Corresponding author. Tel: +44-20-7388-7320; Fax: +44-20-7388-7324; E-mail: i.morrissey{at}grmicro.co.uk